Impact of Hypothalamic Gliosis on Appetite Regulation and Obesity Risk in Children
NCT ID: NCT04260048
Last Updated: 2025-05-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
101 participants
OBSERVATIONAL
2020-02-21
2024-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Postural Assessment in Plagiocephaly
NCT01989286
Sleep-disordered Breathing in Infants With Myelomeningocele
NCT04251806
Examination of Sleep and Family Functioning in Pediatric Craniopharyngioma Patients
NCT03330080
Childhood Body Composition and Brain Structure and Function
NCT01822054
Effect of Usage Time of Helmet in Babies With Deformational Plagiocephaly
NCT03430739
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normal weight
Group defined based on BMI percentile for age and sex.
No interventions assigned to this group
Overweight
Group defined based on BMI percentile for age and sex.
No interventions assigned to this group
With obesity
Group defined based on BMI percentile for age and sex.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI ≥ 15th percentile for age and sex
Exclusion Criteria
* Documented cognitive disorder
* History of major weight loss of 10lbs or more, not due to illness, over the past year
* Eating disorder (e.g. anorexia, bulimia)
* Current use of medications known to alter appetite, body weight or brain response including: Anti-epileptics; Glucocorticoids; Antipsychotics; Stimulants for ADHD
* MRI contraindication (e.g. implanted metal, claustrophobia, inability to fit in MRI scanner)
* Weight \>330 pounds (MRI limit)
* Severe food allergies, vegetarian, or vegan, or unable to eat study foods
* Currently in formal weight loss program
9 Years
11 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johns Hopkins University
OTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
University of Washington
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ellen Schur, MD, MS
Associate Professor, School of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ellen A Schur, MD, MS
Role: PRINCIPAL_INVESTIGATOR
University of Washington
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Johns Hopkins University
Baltimore, Maryland, United States
University of Washington
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SITE00000078
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.